Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- RA Patients Criticized as Selfish, Lazy: Wyeth Survey
January 12, 2004
- BULLETIN
January 12, 2004
- Pharmacokinetic Frequency Analysis Database Jointly Developed by PSC, JBIC
January 12, 2004
- FJPWA Petitions Korosho Regarding Joint Purchasing
January 12, 2004
- DIAGNOSTIC NEWS IN BRIEF
January 12, 2004
- Council Supports Inspection, Payment of Dispensing Bills by Insurers
January 12, 2004
- MEDICAL DEVICE NEWS IN BRIEF
January 12, 2004
- Monkasho Facing 4.5% Budget Cut in FY2004
January 12, 2004
- JACDS to Create Certification System for Kampo Advisors
January 12, 2004
- NEW PRODUCTS
January 12, 2004
- Wholesalers' Profits May Fall 30% This Fiscal Year: Mr Kimura of CR&C
December 29, 2003
- MEDICAL DEVICE NEWS IN BRIEF
December 29, 2003
- FPMAJ to Introduce Bar Code System Starting from Bio-derived Products
December 29, 2003
- WORLD NEWS IN BRIEF
December 29, 2003
- Quintiles' CSO Business Growing Rapidly
December 29, 2003
- The Value of New Medicines
December 29, 2003
- BUSINESS NEWS IN BRIEF
December 29, 2003
- MEETING
December 29, 2003
- Medical Fees Remain Unchanged
December 29, 2003
- Meet the Leaders (28)
December 29, 2003
ページ
Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…